Insecticides India Ltd Valuation Turns Very Attractive Amid Market Pressure

Valuation Metrics Signal Enhanced Price Attractiveness

As of 24 July 2026, Insecticides India Ltd trades at a price of ₹603.35, down 2.93% from the previous close of ₹621.55. The stock has experienced a notable correction from its 52-week high of ₹1,096.30, now closer to its 52-week low of ₹525.90. This price adjustment has contributed to a marked improvement in key valuation ratios.

The company’s price-to-earnings (P/E) ratio currently stands at 12.59, a level that is considered very attractive when compared to its historical valuation and the broader sector. This is a significant improvement from previous assessments that rated the stock’s valuation as fair. The price-to-book value (P/BV) ratio is also modest at 1.44, indicating that the stock is trading near its book value, which often appeals to value investors seeking downside protection.

Other valuation multiples reinforce this positive shift. The enterprise value to EBITDA (EV/EBITDA) ratio is 7.33, and the EV to EBIT ratio is 8.69, both of which are considerably lower than many peers in the pesticides and agrochemicals industry. For instance, Bayer CropScience trades at an EV/EBITDA of 20.35 and a P/E of 27.95, while BASF India’s P/E is 39.06 with an EV/EBITDA of 23.48. These comparisons highlight Insecticides India’s relative undervaluation within its sector.

Peer Comparison Highlights Relative Value

When benchmarked against its peer group, Insecticides India Ltd’s valuation stands out as very attractive. Among comparable companies, Sharda Cropchem and Dhanuka Agritech also exhibit very attractive valuations with P/E ratios of 11.51 and 15.12 respectively, and EV/EBITDA multiples below 11. Conversely, several peers such as Anupam Rasayan and Laxmi Organic are trading at very expensive valuations, with P/E ratios exceeding 60 and EV/EBITDA multiples above 29.

This divergence in valuation metrics suggests that Insecticides India Ltd may be undervalued relative to its growth and profitability prospects, especially given its solid return on capital employed (ROCE) of 17.90% and return on equity (ROE) of 12.17%. These profitability indicators demonstrate efficient capital utilisation and shareholder returns, which are often rewarded with premium valuations in the market.

Market Performance and Risk Considerations

Despite the improved valuation, Insecticides India Ltd’s recent market performance has been underwhelming. The stock has declined 8.71% over the past week and 10.37% over the last month, significantly underperforming the Sensex, which gained 0.25% in the same one-month period. Year-to-date, the stock is down 15.53%, compared to the Sensex’s 10.36% gain. Over the last year, the stock has suffered a steep 38.75% decline, while the Sensex fell by only 7.66%.

Longer-term returns paint a more positive picture, with the stock delivering a 37.91% gain over three years and a 91.43% increase over ten years, though these are still below the Sensex’s respective 14.56% and 174.76% returns. This mixed performance underscores the importance of considering both valuation and momentum factors when evaluating the stock.

Quality and Dividend Metrics

Insecticides India Ltd’s quality metrics remain respectable. The company offers a dividend yield of 0.33%, which, while modest, provides some income support to investors. The PEG ratio is effectively zero, indicating that the stock’s price is not currently factoring in expected earnings growth, which could be a positive sign if earnings improve.

Its market capitalisation is classified as small-cap, which typically entails higher volatility and risk but also potential for greater returns if the company executes well. The recent downgrade in the Mojo Grade from Hold to Sell, with a current Mojo Score of 37.0, reflects caution from the rating agency, likely influenced by the stock’s recent price weakness and sector challenges.

Implications for Investors

The shift in valuation from fair to very attractive suggests that Insecticides India Ltd may be entering a phase where the risk-reward profile improves for value investors. The relatively low P/E and P/BV ratios, combined with solid profitability metrics, indicate that the stock is trading at a discount to its intrinsic worth and sector peers.

However, investors should weigh this against the recent negative price momentum and the downgrade in the Mojo Grade, which signals caution. The small-cap nature of the company also implies higher volatility and sensitivity to sector-specific risks such as regulatory changes, commodity price fluctuations, and agricultural demand cycles.

For those with a longer investment horizon and a tolerance for risk, the current valuation levels may present an attractive entry point. Conversely, more risk-averse investors might prefer to monitor the stock for signs of price stabilisation or improvement in market sentiment before committing capital.

Historical Valuation Context

Historically, Insecticides India Ltd has traded at higher multiples during periods of robust earnings growth and sector tailwinds. The current P/E of 12.59 is well below the levels seen during the stock’s 52-week high price period, reflecting the recent price correction. This re-rating aligns the stock closer to its book value, which has hovered around 1.4 times, a level that has previously acted as a support zone.

Comparing the EV to capital employed ratio of 1.47 and EV to sales of 0.78 further confirms the stock’s undervaluation relative to peers, many of whom trade at multiples exceeding 2.0 on these metrics. Such valuation compression may be temporary if the company can sustain or improve its operational performance and earnings growth.

Conclusion

Insecticides India Ltd’s recent valuation shift to very attractive territory offers a compelling case for investors seeking value in the pesticides and agrochemicals sector. While the stock faces near-term headwinds reflected in its price performance and rating downgrade, its improved price multiples and solid profitability metrics provide a foundation for potential upside.

Investors should balance these factors with the inherent risks of small-cap stocks and sector volatility. A careful, research-driven approach is advisable to determine whether the current valuation represents a genuine buying opportunity or a value trap amid broader market uncertainties.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today